LIMN
Liminatus Pharma, Inc. Class A Common Stock
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$1.43
+$0.36
(+33.64%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $38.70M | EPS (ttm) | $-0.16 | Current Price | $1.43 |
| Enterprise Value | $29.68M | Forward EPS | - | Previous Close | $1.07 |
| P/E Ratio | - | ROA | -48.06% | 52W High | $33.66 |
| Forward P/E | - | ROE | - | 52W Low | $0.54 |
| PEG Ratio | - | Gross Margin | - | 50 Day Avg | $0.78 |
| P/S Ratio | - | Operating Margin | - | 200 Day Avg | $4.28 |
| P/B Ratio | -23.44 | Profit Margin | - | Volume | 96.22M |
| EV/EBITDA | - | Current Ratio | 0.42 | Avg Volume | 1.66M |
| EV/Sales | - | Quick Ratio | 0.25 | Beta | 0.41 |
| Employees | - | Debt/Equity | - | Shares Outstanding | 27.06M |
| Sector | Healthcare | Total Debt | $1.44M | Float Shares | 5.56M |
| Industry | Biotechnology | Total Cash | $724.50K | Short Float | - |
| Optionable | No | Cash/Share | $0.03 | Short Ratio | 0.49 |
| Dividend Yield | - | Book Value/Share | $-0.06 | % Held by Insiders | 79.47% |
| Target Price | - | Revenue (TTM) | - | % Held by Institutions | 0.89% |